We are proud to announce our partnership with Debiopharm, the recent winner of the Swiss Biotech Success Story 2020, at this year’s conference. Debiopharm will host the Frontiers Health Local Hub in compliance with all local sanitary regulations at its headquarters in Lausanne, Switzerland.
Debiopharm develops, manufactures, and invests in innovative therapies and technologies that respond to high unmet medical needs in oncology and bacterial infections. In addition to drug development and manufacturing, Debiopharm aims to provide strategic funding and guidance for companies with an ambition to improve the patient journey and re-imagine how clinical trials are conducted. Since 2018 Debiopharm has invested over USD 120 million, typically leading the investment rounds of its 16 portfolio companies. Its growing portfolio company achievements include 10 FDA clearances, 13 CE marks, 2 IPOs, and 4 trade exits.
Debiopharm will organize a breakout session with a guest panel dedicated to virtual clinical development, available both virtually and physically, at FH20. If you would be interested in attending our conference at Debiopharm’s local hub in Lausanne, please contact us to get your complimentary pass offered from Debiopharm by Oct. 30. Guests joining the offline event will also get access to the whole conference including online sessions accessible by laptop or mobile device.
